Evolent Health (STU:9EH) COGS-to-Revenue : 0.84 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Evolent Health COGS-to-Revenue?

Evolent Health's Cost of Goods Sold for the three months ended in Mar. 2024 was €493 Mil. Its Revenue for the three months ended in Mar. 2024 was €588 Mil.

Evolent Health's COGS to Revenue for the three months ended in Mar. 2024 was 0.84.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Evolent Health's Gross Margin % for the three months ended in Mar. 2024 was 16.28%.

Evolent Health COGS-to-Revenue Historical Data

The historical data trend for Evolent Health's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evolent Health COGS-to-Revenue Chart

Evolent Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.75

0.72

0.77

Evolent Health Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.73	0.75	0.76	0.82	0.84

Evolent Health COGS-to-Revenue Calculation

Evolent Health's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1378.642	/	1800.893
	=	0.77

Evolent Health's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	492.703	/	588.481
	=	0.84

Evolent Health (STU:9EH) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Evolent Health's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	492.703 / 588.481
	=	16.28 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Evolent Health COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Evolent Health's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Evolent Health (STU:9EH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Evolent Health Inc (STU:9EH) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

EVH:USA

Address

800 N. Glebe Road, Suite 500, Arlington, VA, USA, 22203

Website

https://www.evolenthealth.com

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. The company's two reportable segments: EHS and Clinical Solutions. The Company's EHS segment provides an integrated administrative and clinical platform for health plan administration and value-based business infrastructure and clinical Solutions segment addresses a broad spectrum of clinical needs, with tailored solutions for specialty care management in oncology and cardiology and increasingly the musculoskeletal markets and holistic total cost of care improvement. It generates a majority of its revenue from Clinical Solutions segment.

Evolent Health (STU:9EH) Headlines

No Headlines